TherapeuticsMD (TXMD) Current Deferred Revenue (2012 - 2014)

TherapeuticsMD's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $522613.0 for Q4 2014.

• Quarterly Current Deferred Revenue fell 67.39% year-over-year to $522613.0 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $522613.0 (down 67.39% YoY) and the FY2014 annual result came in at $522613.0, down 67.39% from the prior year.
• Current Deferred Revenue was $522613.0 for Q4 2014 at TherapeuticsMD, down from $1.6 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $1.6 million in Q4 2013 and bottomed at $522613.0 in Q4 2014.
• A 3-year average of $955520.7 and a median of $922151.0 in 2012 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2013 — Current Deferred Revenue soared 39.99% — and 2014, when it plunged 67.39%.
• TherapeuticsMD's Current Deferred Revenue stood at $1.1 million in 2012, then soared by 39.99% to $1.6 million in 2013, then plunged by 67.39% to $522613.0 in 2014.
• Business Quant data shows TXMD's Current Deferred Revenue at $522613.0 in Q4 2014, $1.6 million in Q4 2013, and $1.1 million in Q1 2013.